Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

April 30, 2007

Study Completion Date

October 31, 2008

Conditions
Congenital Heart BlockNeonatal LupusAtrioventricular Nodal DysfunctionMyocardial Injury
Interventions
DRUG

Dexamethasone or other corticosteroid

Administered during the third trimester of pregnancy

Trial Locations (4)

10003

Hospital for Joint Diseases, New York

10016

New York University Medical Center, New York

06520

Yale University Medical Center, New Haven

07039

St. Barnabas Medical Center, Livingston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

NYU Langone Health

OTHER

NCT00007358 - Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus | Biotech Hunter | Biotech Hunter